- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Silicon-based ultrasound generates images
Sensant has created the first clinical images using a novel ultrasound technology that uses silicon-based transducers. The images of the carotid artery, breast, and musculoskeletal system were presented for comparison with conventionally made images at
Sensant has created the first clinical images using a novel ultrasound technology that uses silicon-based transducers. The images of the carotid artery, breast, and musculoskeletal system were presented for comparison with conventionally made images at the 10th Congress of the World Federation for Ultrasound in Medicine and Biology in Montreal June 1 to 4. The Montreal-based company generated images in collaboration with staff from Esaote and radiologists at the Valduce Hospital in Como, Italy. Sensant claims its images rival those produced by state-of-the-art ultrasound systems, which rely on piezoelectric crystal technology. The tiny silicon structures, known as capacitive microfabricated ultrasonic transducers, provide superior acoustic response, according to Sensant (SCAN 1/2/03).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
